Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
4.300
-0.040 (-0.92%)
Oct 30, 2025, 4:00 PM EDT - Market closed
Savara Market Cap
Savara has a market cap or net worth of $905.97 million as of October 30, 2025. Its market cap has increased by 50.39% in one year.
Market Cap
905.97M
Enterprise Value
788.83M
1-Year Change
50.39%
Ranking
Category
Stock Price
$4.30
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $905.97M, an increase of 582.72%. That is a compound annual growth rate of 25.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 750.10M | 42.36% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
| Apr 28, 2017 | 132.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.95B |
| Johnson & Johnson | 447.26B |
| AbbVie | 400.48B |
| UnitedHealth Group | 326.07B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Merck & Co. | 217.48B |